Skip to main content

Marina Bataller Fernández

Institutions of which they are part

Predoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Vall Hebron Institut de Recerca

Marina Bataller Fernández

Institutions of which they are part

Predoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Vall Hebron Institut de Recerca

Projects

Establecimiento de una estrategia combinada en carcinoma escamoso de cabeza y cuello (HNSCC): una herramienta eficaz para superar los tumores quimiorresistentes.

IP: Matilde Lleonart Pajarin
Collaborators: Katerin Ingrid Rojas Laimito, Yoelsis Garcia Mayea, Juan Lorente Guerrero, Sergio Benavente Norza, Josep Castellví Vives, Marina Bataller Fernández, Establecimiento de una estrategia combinada en carcinoma escamoso de cabeza y cuello (HNSCC): una herramienta eficaz para supera, Juan Fernando Fuentes Cabrera, Juan Fernando Fuentes Cabrera
Funding agency: Instituto de Salud Carlos III
Funding: 240000
Reference: PI24/00630
Duration: 01/01/2025 - 31/12/2027

NANORESCAN

IP: Matilde Lleonart Pajarin
Collaborators: Katerin Ingrid Rojas Laimito, Irene Braña Garcia, David Virós Porcuna, Josep Castellví Vives, Marina Bataller Fernández, Juan Fernando Fuentes Cabrera, Juan Fernando Fuentes Cabrera
Funding agency: Instituto de Salud Carlos III
Funding: 318750
Reference: AC24/00057
Duration: 01/01/2025 - 31/12/2027

Beca VHIR PhD

IP: Matilde Lleonart Pajarin
Collaborators: Laia Perez Lasarte, Marina Bataller Fernández
Funding agency: Fundació Institut de Recerca HUVH
Funding: 69188.74
Reference: VPHD/MARINA_B
Duration: 01/04/2023 - 31/03/2026

New compounds targeting head and neck cancer as Trojan horses against chemoresistant cells

IP: Matilde Lleonart Pajarin
Collaborators: Yoelsis Garcia Mayea, Marina Bataller Fernández, Gabriela Isabel Fuentes Llopis
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2023 LLAV 00102
Duration: 01/02/2024 - 31/07/2024

Related news

Researchers from the Vall d’Hebron Research Institute (VHIR) have participated in a study showing that, after just a few seconds of illumination, the activated molecule prevents the formation of tumor spheres.

Experts addressed the main current and future challenges to improve therapeutic options for patients with this type of tumor.

The sessions were aimed at establishing new collaborations to advance the prevention and treatment of this type of tumour.

Related professionals

Antonio Luis Andreu Périz

Antonio Luis Andreu Périz

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Read more
Luisa Sofia Silva Alcoser

Luisa Sofia Silva Alcoser

Predoctoral researcher
Translational Molecular Pathology
Read more
Mercedes Crespo Hereu

Mercedes Crespo Hereu

Research technician
Musculoskeletal Tissue Engineering
Read more
Raimundo Molina Martínez

Raimundo Molina Martínez

Gestió i Administració
General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.